Medicare billing address
CMS Medicare provider billing file
169 N Gateway Dr Ste 100Providence, UT 84332
CMS public data · NPI 1598086720
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Cory B Maughan, D.O.
Specialty
Credential
D.O.
NPI
1598086720
Primary source state
UT
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Cory B Maughan, D.O. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
169 N Gateway Dr Ste 100CMS Doctors & Clinicians file
1325 N 600CMS Doctors & Clinicians file
1325 W S Jordan PkwyCMS Doctors & Clinicians file
123 C AveIn the 2024 CMS provider billing file, this NPI had 589 Medicare beneficiaries and 2,043 total services. The average beneficiary age was 76, and the average HCC risk score was 1.1.
Total Medicare allowed amount
$551,864.00
Total Medicare payment amount
$434,798.26
Medicare beneficiaries
589
Total services
2,043
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hypertension
67%
CMS beneficiary-panel share
Hyperlipidemia
58%
CMS beneficiary-panel share
Diabetes
27%
CMS beneficiary-panel share
Chronic kidney disease
25%
CMS beneficiary-panel share
Ischemic heart disease
23%
CMS beneficiary-panel share
Atrial fibrillation
18%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 391 | $590.61 |
| Destruction of precancer skin growth, 2-14 growths | 233 | $6.56 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 151 | $405.76 |
| Destruction of precancer skin growth, 1 growth | 139 | $48.58 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 136 | $90.96 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 108 | $128.43 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 95 | $233.56 |
| Destruction of skin growth, 1-14 growths | 88 | $106.69 |
| Biopsy of related skin growth, first growth | 76 | $78.27 |
| Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | 50 | $603.44 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1598086720. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Mupirocin | Mupirocin | 177 | 178.9 | $1,510.22 |
| 2 | Cephalexin | Cephalexin | 144 | 144 | $986.13 |
| 3 | Fluorouracil | Fluorouracil | 78 | 78.7 | $4,959.10 |
| 4 | Triamcinolone Acetonide | Triamcinolone Acetonide | 64 | 101.1 | $1,066.74 |
| 5 | Clobetasol Propionate | Clobetasol Propionate | 62 | 63 | $1,673.92 |
| 6 | Desoximetasone | Desoximetasone | 16 | 16 | $324.75 |
| 7 | Doxycycline Hyclate | Doxycycline Hyclate | 15 | 17 | $267.56 |
| 8 | Dupixent Pen | Dupilumab | 14 | 14 | $61,560.74 |
| 9 | Spironolactone | Spironolactone | 13 | 13 | $263.82 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Midwestern University, Chicago College Of Osteopathic Med
Graduation year
2010
Group/practice field
Clear Choice Dermatology
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.